Endpoints | For all patients n=200 (% of n) | Oesophagus cancer n=54 (% of n) | Gastric cancer n=132 (% of n) | Combinedâ€ surgery n=14 (% of n) |

Primary endpoint | 11 (5.5%) | 3 (5.5%) | 6 (4.5%) | 2 (14.3)* |

Secondary endpoint | 30 (15.0%) | 8 (14.8%) | 18 (13.6%) | 4 (28.6%)* |

Mann-Whitney U-test.

*Combined surgery versus oesophagus cancer as well as gastric cancer (p=0.0124).

â€ Combined surgery versus gastric cancer (p=0.05).